Real-world outcomes of proliferative diabetic retinopathy
增殖性糖尿病视网膜病变的现实结果
基本信息
- 批准号:10624272
- 负责人:
- 金额:$ 25.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAlgorithmsAnatomyBackground Diabetic RetinopathyBiometryBlindnessCaliforniaCaringClassificationClinicalClinical ResearchClinical Trials DesignClinical effectivenessCodeDataData AnalyticsData SetDatabasesDevelopmentDiabetic RetinopathyDiagnosisDiseaseEffectivenessElectronic Health RecordEligibility DeterminationEnvironmentEthnic OriginEyeEye diseasesFoundational SkillsFoundationsFundingFutureGeneral HospitalsGoalsHealth InsuranceHealthcareHospitalsICD-9ImageInfrastructureInjectionsIntelligenceInterventionKnowledgeLight CoagulationManualsMeasuresMentorsMentorshipMethodsModelingNatural Language ProcessingObservational StudyOphthalmologistOphthalmologyOutcomeOutcome StudyOutpatientsParticipantPatient RecruitmentsPatientsPerformancePharmaceutical PreparationsPhysicians&apos OfficesPragmatic clinical trialProspective StudiesProviderPublishingRaceRandomized, Controlled TrialsRegistriesReportingResearchResearch PersonnelRetinaRetrospective StudiesRisk FactorsSan FranciscoStructureTechniquesTestingTextTimeTrainingTreatment EffectivenessUnited StatesUniversitiesVascular Endothelial Growth FactorsVisionVisualagedbiomedical informaticsclinical data warehousecomparison interventioncost effectivenessdesigndiabeticelectronic health record systemfollow-upfuture implementationhealth disparityhigh riskimprovedimproved outcomeinnovationlow socioeconomic statusmedication compliancenovelophthalmic examinationpredictive modelingpreventprimary outcomeproliferative diabetic retinopathyrisk stratificationroutine carestructured datatooltreatment as usualunstructured data
项目摘要
PROJECT SUMMARY:
Real-world outcomes of proliferative diabetic retinopathy
Vision loss from diabetic retinopathy remains the leading cause of preventable blindness in working-aged
adults in the United States (US). Advanced diabetic retinopathy is referred to as proliferative diabetic
retinopathy (PDR). In many patients, blindness associated with PDR can be prevented with appropriate and
timely diagnosis and treatment. Unfortunately, some patients at high risk for PDR are not receiving adequate
eye care. More knowledge is needed about PDR outcomes in a real-world setting, and the differences between
published study outcomes and real-world effectiveness. Electronic health records (EHRs) are used in nearly
90% of outpatient physician offices and can be a powerful tool for studying PDR in a real-world setting. The
goal of this proposal is to develop and validate EHR-based methods to improve outcomes in PDR. The study
aims are: (1) to classify patients with PDR in the EHR system using an automated method that incorporates
structured (e.g., diagnosis code, medications, labs) and unstructured data (e.g., clinical notes), (2) to predict
the progression of non-proliferative diabetic retinopathy to PDR using a forecasting model with time-varying
covariates, and (3) to determine the real-world effectiveness of treatments for PDR in a large nationwide eye
dataset. The study will utilize data from the University of California San Francisco’s (UCSF) De-Identified
Clinical Data Warehouse, a de-identified EHR with over 1 million patients that has available eye exam
information, and the Intelligent Research in Sight (IRIS) registry, a nationwide comprehensive eye database
that includes data from over 15,000 eye providers in the US with over 1 million patients with PDR. The
innovative methods and tools from this study can be applied to other eye conditions to facilitate future EHR-
based clinical studies in ophthalmology. The candidate, Dr. Catherine Sun is an ophthalmologist whose long-
term goal is to study real-world clinical outcomes in ophthalmology by conducting EHR-based pragmatic
clinical trials and using large-scale EHR data. While she possesses the foundational skills, additional mentored
training and coursework in data analytics, biomedical informatics, biostatistics, and advanced clinical trial
design and implementation will help her reach her goals. Her outstanding mentorship team of primary mentor
Dr. Nisha Acharya and co-mentors Dr. Travis Porco and Dr. Joshua Stein, and the exceptional environment of
the Department of Ophthalmology and the F.I. Proctor Foundation at UCSF will support Dr. Sun’s development
into an R01-funded independent investigator.
项目概要:
增殖性糖尿病视网膜病变的现实结果
糖尿病视网膜病变导致的视力丧失仍然是工作年龄组可预防性失明的主要原因
在美国,晚期糖尿病视网膜病变被称为增殖性糖尿病。
在许多患者中,通过适当和适当的治疗可以预防与 PDR 相关的失明。
不幸的是,一些 PDR 高风险患者没有得到足够的诊断和治疗。
需要更多关于现实环境中的 PDR 结果以及之间的差异的知识。
已发表的研究结果和现实世界的有效性几乎被使用。
90% 的门诊医生办公室,可以成为在现实环境中研究 PDR 的强大工具。
该提案的目标是开发和验证基于 EHR 的方法,以改善 PDR 的结果。
目标是:(1) 使用自动化方法对 EHR 系统中的 PDR 患者进行分类
结构化(例如诊断代码、药物、实验室)和非结构化数据(例如临床记录),(2) 进行预测
使用时变预测模型研究非增殖性糖尿病视网膜病变进展为 PDR
协变量,以及 (3) 确定 PDR 治疗在全国范围内的真实有效性
该研究将利用来自加州大学旧金山分校 (UCSF) 的去识别数据。
临床数据仓库,一个去识别化的 EHR,拥有超过 100 万患者,可以进行眼科检查
信息,以及智能视觉研究 (IRIS) 注册中心,这是一个全国性的综合眼科数据库
其中包括来自美国 15,000 多家眼科服务提供者的数据,其中包括超过 100 万 PDR 患者。
这项研究的创新方法和工具可以应用于其他眼部疾病,以促进未来的 EHR-
候选人 Catherine Sun 博士是一位眼科医生,长期从事眼科临床研究。
术语目标是通过进行基于 EHR 的实用性研究来研究眼科的真实临床结果
虽然她拥有基础技能,但她还接受了额外的指导。
数据分析、生物医学信息学、生物统计学和高级临床试验的培训和课程
设计和实施将帮助她实现她的目标。
Nisha Acharya 博士和联合导师 Travis Porco 博士和 Joshua Stein 博士,以及卓越的环境
加州大学旧金山分校眼科和 F.I. Proctor 基金会将支持孙博士的发展
成为 R01 资助的独立调查员。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Improving Outcomes in Neovascular Glaucoma.
- DOI:10.1016/j.ogla.2021.12.001
- 发表时间:2022-03
- 期刊:
- 影响因子:2.9
- 作者:Qiu, Mary;Shukla, Aakriti Garg Q.;Sun, Catherine
- 通讯作者:Sun, Catherine
Developing and Validating Models to Predict Progression to Proliferative Diabetic Retinopathy.
- DOI:10.1016/j.xops.2023.100276
- 发表时间:2023-06
- 期刊:
- 影响因子:0
- 作者:Guo, Yian;Yonamine, Sean;Ma, Chu Jian;Stewart, Jay M.;Acharya, Nisha;Arnold, Benjamin F.;McCulloch, Charles;Sun, Catherine Q.
- 通讯作者:Sun, Catherine Q.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine Qing Sun其他文献
Catherine Qing Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine Qing Sun', 18)}}的其他基金
Real-world outcomes of proliferative diabetic retinopathy
增殖性糖尿病视网膜病变的现实结果
- 批准号:
10191673 - 财政年份:2021
- 资助金额:
$ 25.6万 - 项目类别:
Real-world outcomes of proliferative diabetic retinopathy
增殖性糖尿病视网膜病变的现实结果
- 批准号:
10396571 - 财政年份:2021
- 资助金额:
$ 25.6万 - 项目类别:
相似国自然基金
地表与大气层顶短波辐射多分量一体化遥感反演算法研究
- 批准号:42371342
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
高速铁路柔性列车运行图集成优化模型及对偶分解算法
- 批准号:72361020
- 批准年份:2023
- 资助金额:27 万元
- 项目类别:地区科学基金项目
随机密度泛函理论的算法设计和分析
- 批准号:12371431
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
基于全息交通数据的高速公路大型货车运行风险识别算法及主动干预方法研究
- 批准号:52372329
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高效非完全信息对抗性团队博弈求解算法研究
- 批准号:62376073
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
Exploratory Analysis Tools for Developmental Studies of Brain Microstructure with Diffusion MRI
利用扩散 MRI 进行脑微结构发育研究的探索性分析工具
- 批准号:
10645844 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
In vivo feasibility of a smart needle ablation treatment for liver cancer
智能针消融治疗肝癌的体内可行性
- 批准号:
10699190 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
Quantitative imaging of choroid plexus function and neurofluid circulation in Alzheimer's Disease Related Dementia
阿尔茨海默病相关痴呆症脉络丛功能和神经液循环的定量成像
- 批准号:
10718346 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
AI-empowered 3D Computer Vision and Image-Omics Integration for Digital Kidney Histopathology
AI 赋能的 3D 计算机视觉和图像组学集成用于数字肾脏组织病理学
- 批准号:
10635439 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
A ratcheting pediatric prosthetic finger using advanced rapid manufacturing technology
采用先进快速制造技术的棘轮儿童假肢手指
- 批准号:
10760098 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别: